To combat globally high prices of insulin, the World Health Organisation (W.H.O) has announced an initiative to allow drug companies to produce biosimilar insulin products. This would be through a...
To combat globally high prices of insulin, the World Health Organisation (W.H.O) has announced an initiative to allow drug companies to produce biosimilar insulin products. This would be through a...
